Literature DB >> 15698678

Confirmatory factor analysis of the Neurological Evaluation Scale in unmedicated schizophrenia.

Richard D Sanders1, Daniel N Allen, Steven D Forman, Thaddeus Tarpey, Matcheri S Keshavan, Gerald Goldstein.   

Abstract

Factor structure of the Neurological Evaluation Scale (NES) was evaluated in 95 unmedicated patients with schizophrenia using confirmatory factor analysis (CFA). CFA was used to test four competing models that were based on prior empirical work examining the factor structure of the NES, as well as on theoretical considerations. A three-factor solution composed of "repetitive motor," "cognitive-perceptual," and "balance-tandem" factors best accounted for the data. These findings are consistent with prior exploratory studies that have suggested the NES is a multidimensional procedure that assesses diverse neurological domains. The current results contribute to the development of empirical subscales for neurological assessment procedures to be used in psychiatric conditions.

Entities:  

Mesh:

Year:  2005        PMID: 15698678     DOI: 10.1016/j.psychres.2004.10.005

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  7 in total

1.  A broad cortical reserve accelerates response to cognitive enhancement therapy in early course schizophrenia.

Authors:  Matcheri S Keshavan; Shaun M Eack; Jessica A Wojtalik; Konasale M R Prasad; Alan N Francis; Tejas S Bhojraj; Deborah P Greenwald; Susan S Hogarty
Journal:  Schizophr Res       Date:  2011-06-08       Impact factor: 4.939

2.  Paternal age and specific neurological soft signs as reliable and valid neurobiological markers for the diagnosis of patients with schizophrenia.

Authors:  Konstantinos N Fountoulakis; Panagiotis Panagiotidis; Thomas Tegos; Vasileios Kimiskidis; Ioannis Nimatoudis
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2021-11-29       Impact factor: 5.760

3.  Neurological abnormalities among offspring of persons with schizophrenia: relation to premorbid psychopathology.

Authors:  Konasale M Prasad; Richard Sanders; John Sweeney; Debra Montrose; Vaibhav Diwadkar; Diana Dworakowski; Jean Miewald; Matcheri Keshavan
Journal:  Schizophr Res       Date:  2008-12-23       Impact factor: 4.939

4.  Exploratory factor structure of the neurological evaluation scale in black africans with first episode schizophrenia.

Authors:  Akin Ojagbemi; Robin Emsley; Oye Gureje
Journal:  Data Brief       Date:  2016-01-06

5.  Neurological soft signs: Effects of trait schizotypy, psychological distress and auditory hallucination predisposition.

Authors:  Saskia de Leede-Smith; Steven Roodenrys; Lauren Horsley; Shannen Matrini; Erin Mison; Emma Barkus
Journal:  Schizophr Res Cogn       Date:  2016-12-23

Review 6.  The neural substrates of neurological soft signs in schizophrenia: a systematic review.

Authors:  Genelle D Samson; Adrienne C Lahti; Nina V Kraguljac
Journal:  Schizophrenia (Heidelb)       Date:  2022-04-26

7.  Protein modifications as potential biomarkers in breast cancer.

Authors:  Hongjun Jin; Richard C Zangar
Journal:  Biomark Insights       Date:  2009-11-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.